151 related articles for article (PubMed ID: 38291818)
1. Diagnostic accuracy of a novel point-of-care test for simultaneous detection of anti-transglutaminase IgA and anti-deamidated gliadin IgG antibodies.
Parrinello G; Da Re M; Grizzo F; Camelliti S; Cozzi M; Marinoni F; Villalta D
J Clin Lab Anal; 2024 Feb; 38(3):e25003. PubMed ID: 38291818
[TBL] [Abstract][Full Text] [Related]
2. Deamidated Gliadin Antibodies: Do They Add to Tissue Transglutaminase-IgA Assay in Screening for Celiac Disease?
Abdulrahim A; Fagih M; Troncone R; Bashir MS; Asery A; Alruwaithi M; Al-Jurayyan AN; Al-Alallah I; Al-Hussaini A
J Pediatr Gastroenterol Nutr; 2021 May; 72(5):e112-e118. PubMed ID: 33346579
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
Sayed SK; Imam HM; Mahran AM; Refaiy AM
Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of deamidated gliadin peptide antibodies in diagnosing coeliac disease in children younger than 3 years old.
Hill M; Watkins R; Leonard-Puppa E; Waddell J; Blanchard S; Kader H
J Paediatr Child Health; 2022 May; 58(5):815-819. PubMed ID: 34866267
[TBL] [Abstract][Full Text] [Related]
5. Deamidated gliadin peptide and tissue transglutaminase antibodies in children with coeliac disease: A correlation study.
Saadah OI; Alamri AM; Al-Mughales JA
Arab J Gastroenterol; 2020 Sep; 21(3):174-178. PubMed ID: 32732170
[TBL] [Abstract][Full Text] [Related]
6. IgA anti-tissue transglutaminase antibodies and IgG antibodies against deamidated gliadin peptides as predictors of celiac disease.
Ortiz G; Messere G; Toca MDC; Fiorucci M; Bigliardi R; Vidal J; Reynoso R
Arch Argent Pediatr; 2019 Feb; 117(1):52-55. PubMed ID: 30652447
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy of IgA Anti-Transglutaminase and IgG Anti-Deamidated Gliadin for Diagnosis of Celiac Disease in Children under Two Years of Age: A Systematic Review and Meta-Analysis.
Catassi GN; Pulvirenti A; Monachesi C; Catassi C; Lionetti E
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010880
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performances of celiac disease serological tests among Saudi patients.
Sghiri R; Hassine HB; Almogren A; Shakoor Z; Alswayyed M
Saudi J Gastroenterol; 2023; 29(1):31-38. PubMed ID: 36571384
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease.
Vermeersch P; Geboes K; Mariën G; Hoffman I; Hiele M; Bossuyt X
Clin Chim Acta; 2010 Jul; 411(13-14):931-5. PubMed ID: 20171961
[TBL] [Abstract][Full Text] [Related]
10. To DGP-IgG or not? a comparison of TTG-IgA and DGP-IgG.
Pacheco MC; Lee D; Dickerson J
Clin Chim Acta; 2022 Jun; 531():382-385. PubMed ID: 35550816
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
Agardh D
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.
Mozo L; Gómez J; Escanlar E; Bousoño C; Gutiérrez C
J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):50-5. PubMed ID: 22197936
[TBL] [Abstract][Full Text] [Related]
13. Early diagnosis of celiac disease in IgA deficient children: contribution of a point-of-care test.
Bienvenu F; Anghel SI; Besson Duvanel C; Guillemaud J; Garnier L; Renosi F; Lachaux A; Bienvenu J
BMC Gastroenterol; 2014 Nov; 14():186. PubMed ID: 25376178
[TBL] [Abstract][Full Text] [Related]
14. Office-Based Point of Care Testing (IgA/IgG-Deamidated Gliadin Peptide) for Celiac Disease.
Lau MS; Mooney PD; White WL; Rees MA; Wong SH; Hadjivassiliou M; Green PHR; Lebwohl B; Sanders DS
Am J Gastroenterol; 2018 Aug; 113(8):1238-1246. PubMed ID: 29915400
[TBL] [Abstract][Full Text] [Related]
15. Performance Assessment of a Novel Multianalyte Methodology for Celiac Disease Biomarker Detection and Evaluation of the Serology-Alone Criteria for Biopsy-Free Diagnosis.
Novis CL; Wahl E; Camacho E; Aure MA; Mahler M; Nandakumar V
Arch Pathol Lab Med; 2023 Dec; 147(12):1422-1430. PubMed ID: 36856668
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease.
Olen O; Gudjónsdóttir AH; Browaldh L; Hessami M; Elvin K; Liedberg AS; Neovius M; Grahnquist L
J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):695-700. PubMed ID: 22722680
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease.
Niveloni S; Sugai E; Cabanne A; Vazquez H; Argonz J; Smecuol E; Moreno ML; Nachman F; Mazure R; Kogan Z; Gomez JC; Mauriño E; Bai JC
Clin Chem; 2007 Dec; 53(12):2186-92. PubMed ID: 17901114
[TBL] [Abstract][Full Text] [Related]
18. In Screening for Celiac Disease, Deamidated Gliadin Rarely Predicts Disease When Tissue Transglutaminase Is Normal.
Gould MJ; Brill H; Marcon MA; Munn NJ; Walsh CM
J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):20-25. PubMed ID: 30052564
[TBL] [Abstract][Full Text] [Related]
19. Performance of deamidated gliadin peptide antibodies as first screening for celiac disease in the general pediatric population.
Al-Hussaini A; Al-Jurayyan A; Alharbi S; Salman Bashir M; Troncone R
Front Pediatr; 2023; 11():1279825. PubMed ID: 38078323
[TBL] [Abstract][Full Text] [Related]
20. Correlation analysis of celiac sprue tissue transglutaminase and deamidated gliadin IgG/IgA.
Marietta EV; Rashtak S; Murray JA
World J Gastroenterol; 2009 Feb; 15(7):845-8. PubMed ID: 19230045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
